Aerovate Therapeutics Inc. (AVTE) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Aerovate Therapeutics Inc...

    NASDAQ: AVTE · Real-Time Price · USD
    2.68
    0.00 (0.00%)
    At close: Apr 28, 2025, 3:59 PM

    Aerovate Therapeutics Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 33.75M 23.49M 22.4M 54.2M
    Short-Term Investments
    		 44.87M 98.95M 106.82M 113.18M
    Long-Term Investments
    		 n/a n/a n/a n/a
    Other Long-Term Assets
    		 n/a 2.28M 2.56M 302K
    Receivables
    		 n/a n/a n/a n/a
    Inventory
    		 n/a n/a n/a n/a
    Other Current Assets
    		 845K 250K 295K 240K
    Total Current Assets
    		 80.12M 124.23M 131.5M 174.33M
    Property-Plant & Equipment
    		 215K 902K 1.25M 728K
    Goodwill & Intangibles
    		 n/a n/a n/a n/a
    Total Long-Term Assets
    		 215K 3.19M 3.81M 1.03M
    Total Assets
    		 80.33M 127.42M 135.3M 175.36M
    Account Payables
    		 224K 2.4M 2.58M 1.21M
    Deferred Revenue
    		 n/a n/a n/a 1.01M
    Short-Term Debt
    		 n/a n/a 385K 192K
    Other Current Liabilities
    		 319K 1.09M 2.75M 168K
    Total Current Liabilities
    		 3.83M 17.64M 7.78M 2.55M
    Long-Term Debt
    		 n/a n/a n/a n/a
    Other Long-Term Liabilities
    		 70K 70K 71K 13K
    Total Long-Term Liabilities
    		 70K 325K 776K 395K
    Total Liabilities
    		 3.9M 17.96M 8.56M 2.94M
    Total Debt
    		 417K 675K 1.09M 574K
    Book Value
    		 76.43M 109.46M 126.74M 172.42M
    Book Value Per Share
    		 2.67 4.16 5.18 7.06
    Common Stock
    		 3K 3K 2K 2K
    Retained Earnings
    		 -233.05M -163.42M -87.9M -36.39M
    Comprehensive Income
    		 105K 237K -466K -59K
    Shareholders Equity
    		 76.43M 109.46M 126.74M 172.42M
    Total Investments
    		 44.87M 98.95M 106.82M 113.18M

    Add to Watchlist